Baldwin Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Baldwin Investment Management's AMGN Position: Q2 2026 in Review
Baldwin Investment Management reduced its Amgen (AMGN) stake by 2.6% in Q2 2026, selling an estimated $5.13K and leaving 564 shares worth $204K. The position accounts for 0.02% of the portfolio, ranked #230.
Baldwin Investment Management first reported a position in AMGN in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.08M in Q1 2021. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Baldwin Investment Management held 564 shares of Amgen worth $204K as of Q2 2026.
- Baldwin Investment Management sold 15 Amgen shares in Q2 2026, an estimated $5.13K.
- Amgen made up 0.02% of Baldwin Investment Management's portfolio in Q2 2026, its #230 holding.
- Baldwin Investment Management first reported a position in Amgen in Q3 2020 and has held it in 14 quarters since.
- Baldwin Investment Management's Amgen position peaked at $1.08M in Q1 2021.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Baldwin Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.